BioSim™ Certolizumab pegol (Cimzia®)(Human) ELISA Kit

Certolizumab pegol is an anti-TNF (anti-tumour necrosis factor) drug. It blocks the action of TNF protein and so reduces inflammation in conditions including rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis. BioSim™ Vedolizumab ELISA kit is a Solid phase enzyme-linked immunosorbent assay (ELISA) based on the sandwich principle. Standards and samples (serum or plasma) are incubated in the microtitre plate coated with the reactant for Certolizumab pegol (Cimzia®). After incubation, the wells are washed. A horse radish peroxidase (HRP) conjugated probe is added and binds to Certolizumab pegol captured by the reactant on the surface of the wells. Following incubation wells are washed and the bound enzymatic activity is detected by addition of chromogen-substrate. The color developed is proportional to the amount of Certolizumab pegol in the sample or standard.

Alternate Name: Certolizumab pegol (Cimzia®) ELISA Kit,BioSim™ Certolizumab pegol ELISA Kit

Tag Line: A Sandwich ELISA kit for the qualitative detect Certolizumab pegol in human serum or plasma.

Summary: N/A

Detection Method: Absorbance (450 nm)

Sample Type: Plasma,Serum

Species Reactivity: Human

Applications: Detection Range: 12 - 1000 ng/ml,Cross Reactivity: Except for Certolizumab pegol, there is no cross reaction with other therapeutic antibodies and native serum immunoglobins,Sensitivity: 12 ng/ml,Assay Precision: Intra-Assay: CV < 15%; Inter-Assay: CV < 15% (CV (%) = SD/mean X 100),Recovery rate: 85 – 115% with normal human serum samples with known concentrations,This ELISA kit is used for in vitro quantitative determination of Certolizumab pegol

Features & Benefits: This ELISA kit is used for in vitro quantitative determination of Certolizumab pegol,Assay Precision: Intra-Assay: CV < 15%; Inter-Assay: CV < 15% (CV (%) = SD/mean X 100),Sensitivity: 12 ng/ml,Detection Range: 12 - 1000 ng/ml,Cross Reactivity: Except for Certolizumab pegol, there is no cross reaction with other therapeutic antibodies and native serum immunoglobins.,Recovery rate: 85 – 115% with normal human serum samples with known concentrations